Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic Safety of Kaletra vs Nevirapine in HIV/HCV Co-infected Patients
NCT00661349Phase 4Terminated
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Feb 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Hepatic rigidity increase at 144 weeks. Started Feb 2008; status: terminated.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00661349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661349.